Dual Targeting of mTOR and Aurora-A Kinase for the Treatment of Uterine Leiomyosarcoma
Kari J. Brewer Savannah(The University of Texas MD Anderson Cancer Center), Dina Lev(Assuta Medical Center), Roman Belousov(The University of Texas MD Anderson Cancer Center), Elizabeth G. Demicco(Harvard University), Chad J. Creighton(Baylor College of Medicine), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Matthew L. Anderson(Institute for Molecular Medicine), Kristelle Lusby(The University of Texas MD Anderson Cancer Center), Raphael E. Pollock(The University of Texas MD Anderson Cancer Center), Eric D. Young(The University of Texas MD Anderson Cancer Center), Yiqun Zhang(Baylor College of Medicine), Markus PH. Ghadimi(Düsseldorf University Hospital), Kai-Lieh Huang(The University of Texas MD Anderson Cancer Center), Kelly K. Hunt(The University of Texas MD Anderson Cancer Center)
Cited by 51
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k